Simply Solventless Concentrates Ltd. specializes in cultivating and manufacturing terpene-rich solventless concentrates for various markets. The company faces significant financial challenges, with a gross margin of -9.3% and a net margin of -94.0%, indicating ongoing losses. Additionally, liquidity ratios are concerning, with a current ratio of 0.76 and a quick ratio of 0.21, suggesting potential difficulties in meeting short-term obligations. Despite a recent price increase of 11.11%, the overall financial health raises red flags for investors.
Loading financial metrics...
Gross profit margin declined from 35.3% to 1.3% year-over-year, suggesting pricing pressure or rising input costs are squeezing profitability.
Company posted a loss of $-13.3M over the last year, representing 48.1% of revenue.
Exceptional revenue growth of 578.6% YoY demonstrates strong market demand and competitive positioning.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2025-FY (December 31, 2025)